Filter News
Area of Research
News Topics
- (-) Biomedical (1)
- (-) Computer Science (1)
- (-) Materials Science (2)
- (-) Security (1)
- Artificial Intelligence (1)
- Biology (2)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (2)
- Frontier (1)
- Materials (3)
- Neutron Science (12)
- Physics (2)
- Quantum Science (1)
- Space Exploration (1)
Media Contacts
![Paul Langan will oversee ORNL's research directorate focused on biological and environmental systems science. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-12/2019-P15617_0.jpg?h=bf9cb32e&itok=4n50VPVf)
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
![Mars Rover 2020](/sites/default/files/styles/list_page_thumbnail/public/2019-03/Mars_0.jpg?h=c44fcfa1&itok=gSstQOJO)
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
![Illustration of the intricate organization of the PKA structure, wherein different parts of the protein are connected through elaborate hydrogen bonding networks (dashed yellow lines), glued together by the hydrophobic assemblies (light blue and orange volumes)—all working together to build the functional active site. Insert shows protonation of the transferred phosphoryl group (cyan mesh) and its many interactions with water and the active site amino acid residues. Credit: Jill Hemman/ORNL](/sites/default/files/styles/list_page_thumbnail/public/2019-03/19-G00204_MR_graphic_Kovalevsky_proof5_2.png?h=b7fbb1a9&itok=wrZFNX-o)
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.